Chuck Royce's BBIO Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 232,923 shares of BridgeBio Pharma, Inc. (BBIO) worth $12.1 M, representing 0.12% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Chuck Royce has maintained this position in BBIO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 46,994 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's BridgeBio Pharma (BBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly BridgeBio Pharma (BBIO) Trades by Chuck Royce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2024 | +121,955 | New Buy | 121,955 | $25.46 |
| Q4 2024 | +22,833 | Add 18.72% | 144,788 | $27.44 |
| Q1 2025 | +46,994 | Add 32.46% | 191,782 | $34.57 |
| Q2 2025 | +30,523 | Add 15.92% | 222,305 | $43.18 |
| Q3 2025 | +10,618 | Add 4.78% | 232,923 | $51.94 |
Chuck Royce's BridgeBio Pharma Investment FAQs
Chuck Royce first purchased BridgeBio Pharma, Inc. (BBIO) in Q3 2024, acquiring 121,955 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held BridgeBio Pharma, Inc. (BBIO) for 5 quarters since Q3 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's largest addition to BridgeBio Pharma, Inc. (BBIO) was in Q3 2024, adding 121,955 shares worth $3.1 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Chuck Royce's firm, Royce & Associates Lp, owns 232,923 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $12.1 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, BridgeBio Pharma, Inc. (BBIO) represents approximately 0.12% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's peak holding in BridgeBio Pharma, Inc. (BBIO) was 232,923 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.